Zoledronic acid in nine patients with transient osteoporosis of the hip

Clin Rheumatol. 2020 Jan;39(1):291-293. doi: 10.1007/s10067-019-04840-7. Epub 2019 Nov 23.

Authors

Gerasimos Evangelatos¹, George E Fragoulis², Alexios Iliopoulos³

Affiliations

¹ Rheumatology Department, 417 Army Share Fund Hospital (NIMTS), Athens, Greece. gerevag@gmail.com.
² Rheumatology Unit, First Department of Propaedeutic Internal Medicine, School of Medicine, National and Kapodistrian University of Athens, Athens, Greece.
³ Rheumatology Department, 417 Army Share Fund Hospital (NIMTS), Athens, Greece.

PMID: 31760542
DOI: 10.1007/s10067-019-04840-7

No abstract available

Publication types

Letter

MeSH terms

Adult
Bone Density Conservation Agents / administration & dosage*
Bone Density*
Female
Hip Fractures / diagnostic imaging
Hip Fractures / prevention & control
Humans
Infusions, Intravenous
Magnetic Resonance Imaging
Male
Middle Aged
Osteoporosis / diagnostic imaging
Osteoporosis / drug therapy*
Osteoporosis, Postmenopausal
Zoledronic Acid / administration & dosage*

Substances

Bone Density Conservation Agents
Zoledronic Acid